Amends TCA Title 8; Title 56; Title 63; Title 68 and Title 71.
Tennessee SB2081 expands the existing prohibition against step therapy protocols for health benefit plans that require prior authorization for prescription drugs related to cancer treatment. The bill broadens the scope from only covering patients with stage 4 advanced metastatic cancer or metastatic blood cancer to include any cancer diagnosis. This change affects enrollees diagnosed with cancer, ensuring they have more immediate access to necessary medications without the step therapy requirement.
Tennessee SB2081 expands the existing prohibition against step therapy protocols for health benefit plans that require prior authorization for prescription drugs related to cancer treatment. The bill broadens the scope from only covering patients with stage 4 advanced metastatic cancer or metastatic blood cancer to include any cancer diagnosis. This change affects enrollees diagnosed with cancer, ensuring they have more immediate access to necessary medications without the step therapy requirement.
Track Tennessee Legislation Like a Pro
Join hundreds of professionals using LegisGo to stay ahead of legislative changes.
Instant Alerts
Get notified when bills you track move through the legislature
AI Summaries
Understand complex legislation in seconds with AI-powered analysis
Full Access
All 132 legislators, committee schedules, and voting records
Watson, Bo
114th General Assembly
January 22, 2026
May 26, 2026
Comp. became Pub. Ch. 995